ÂÜÀòÂÒÂ×

Coralie Muzi (Petit) has a solid background in scientific research and drug development. Coralie is currently working as an Associate Scientist at Calliditas Therapeutics AB since April 2022.

Prior to their current role, Coralie worked at Genkyotex S.A for over 10 years, starting in September 2011. During their time there, they served as an Associate Scientist, primarily focusing on inflammation, fibrotic, and metabolic diseases. Coralie'sresponsibilities included developing and establishing new in vivo models and cellular assays, routine drug screening and profiling activities, as well as collaborating on translational science and biomarker projects. Coralie remained with Genkyotex S.A until April 2022.

Before Genkyotex S.A, Coralie worked at Addex Therapeutics as an in vivo and in vitro technician in PK/Toxicology (NCD) from May 2007 to August 2011.

Coralie Muzi (Petit) completed their education in Virology and Molecular Biology at Université Paris Cité, earning a Master's degree from 2004 to 2005. Prior to that, they attended École Pratique des Hautes Études from 2001 to 2003, where they obtained a Diplome de l'EPHE equivalent to a Master's degree in Virology Biology. Coralie also holds a Technical Diploma (DUT) in Biology/Biological Sciences, General from the University of Lille 1 Sciences and Technology, which they completed from 1998 to 2000. Additionally, they underwent professional training in biotechnology bioindustry at l'ESTBB, specializing in the "parcours de professionnalisation" IPROB 5.

Furthermore, Coralie Muzi (Petit) has obtained several additional certifications. In February 2020, they completed the "Les bases en prévention des risques professionnels" program at INRS France. In October 2019, they obtained the "Éléments de Santé au Travail" certification from CNAM. Additionally, they achieved the "MOOC Gestion de Projet, attestation session 9, parcours avancé" certificate from MOOC Gestion de Projet in March 2017.